CPR Less Likely for Cardiac Arrests in Black Neighborhoods

Share this content:
CPR Less Likely for Cardiac Arrests in Black Neighborhoods
CPR Less Likely for Cardiac Arrests in Black Neighborhoods

THURSDAY, Aug. 31, 2017 (HealthDay News) -- In cases of cardiac arrest, the racial make-up of the neighborhood may determine the likelihood of receiving cardiopulmonary resuscitation (CPR) from a passer-by or having access to a public defibrillator, according to a study published online Aug. 30 in JAMA Cardiology.

Researchers analyzed cardiac arrest data from seven U.S. cities: Birmingham, Ala.; Dallas-Fort Worth; Pittsburgh; Portland, Ore.; Seattle, and Milwaukee. Using U.S. Census data, the study authors also examined the demographic information of neighborhoods within these cities. The team identified 22,816 cases in which cardiac arrest occurred outside of a hospital during a four-year period, starting in 2008. Overall, 39.5 percent of those who experienced cardiac arrest outside of the hospital received bystander CPR.

The investigators noted, however, rates of bystander CPR were 43.0 percent in white neighborhoods, compared to only 18.0 percent in black neighborhoods. Similarly, use of an automated external defibrillator occurred more often in white areas. In these neighborhoods, 4.5 percent of cardiac arrest victims received bystander defibrillation 0.9 percent of the victims in black neighborhoods. These racial disparities dramatically reduced rates of survival in mostly black neighborhoods, the researchers noted.

"Bystander treatments and survival after out-of-hospital cardiac arrest are significantly lower in neighborhoods with a higher percentage of black residents. Black and white patients with out-of-hospital cardiac arrest had similar survival in each neighborhood quantile," the authors write. "Novel education and implementation efforts are needed to improve resuscitation outcomes in these neighborhoods."

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »